Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/dna-based-therapeutics-and-dna-delivery-systems-a-comprehensive-review-jbkrBvyHWE
References (165)
-
Hans Hofland, Lee Shephard, Sean Sullivan (1996)
Formation of stable cationic lipid/DNA complexes for gene transfer.Proceedings of the National Academy of Sciences of the United States of America, 93 14
-
Saghir Akhtar (1998)
Antisense technology: selection and delivery of optimally acting antisense oligonucleotides.Journal of drug targeting, 5 4
-
L. Qin, Y. Ding, D. Pahud, E. Chang, M. Imperiale, J. Bromberg (1997)
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.Human gene therapy, 8 17
-
C. Uherek, W. Wels (2000)
DNA-carrier proteins for targeted gene delivery.Advanced drug delivery reviews, 44 2-3
-
K. Roy, H. Mao, Shau-ku Huang, K. Leong (1999)
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergyNature Medicine, 5
-
(2002)
Dendrimers: synthesis and applications. Microspheres, Microcapsules & Liposomes -
Y. Lien, L. Lai (2002)
Gene Therapy for Renal DisordersDrugs & Aging, 19
-
W. Walther, U. Stein (2000)
Viral vectors for gene transfer: a review of their use in the treatment of human diseases.Drugs, 60 2
-
P. Tam, M. Monck, D. Lee, O. Ludkovski, E. Leng, K. Clow, H. Stark, P. Scherrer, R. Graham, P. Cullis (2000)
Stabilized plasmid-lipid particles for systemic gene therapy.Gene therapy, 7 21
-
S. Crooke (1998)
Molecular mechanisms of antisense drugs: RNase H.Antisense & nucleic acid drug development, 8 2
-
Feng Liu, Leaf Huang (2002)
Development of non-viral vectors for systemic gene delivery.Journal of controlled release : official journal of the Controlled Release Society, 78 1-3
-
R. Stull, Jr Szoka (1995)
Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and ProspectsPharmaceutical Research, 12
-
T. Doan (2001)
Cell binding and internalisation of oligonucleotidesStp Pharma Sciences, 11
-
E. Fattal, C. Dubernet, P. Couvreur (2001)
Liposome-based formulations for the delivery of oligonucleotidesStp Pharma Sciences, 11
-
D. McAllister, M. Allen, M. Prausnitz (2000)
Microfabricated microneedles for gene and drug delivery.Annual review of biomedical engineering, 2
-
P. Monnard, T. Oberholzer, P. Luisi (1997)
Entrapment of nucleic acids in liposomes.Biochimica et biophysica acta, 1329 1
-
D. Chadwick, G. Cardew (1997)
Ciba Foundation Symposium 209 - Oligonucleotides as Therapeutic Agents -
S. Raper, N. Chirmule, F. Lee, N. Wivel, A. Bagg, G. Gao, James Wilson, M. Batshaw (2003)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.Molecular genetics and metabolism, 80 1-2
-
Helen Fitzsimons, R. Bland, M. During (2002)
Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.Methods, 28 2
-
V. Soultrait, P. Lozach, R. Altmeyer, L. Tarrago-Litvak, S. Litvak, M. Andreola (2002)
DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.Journal of molecular biology, 324 2
-
W. Denny (2003)
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)Journal of Biomedicine and Biotechnology, 2003
-
Qing Ge, Michael McManus, T. Nguyen, Ching-Hung Shen, P. Sharp, H. Eisen, Jianzhu Chen (2003)
RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcriptionProceedings of the National Academy of Sciences of the United States of America, 100
-
Joseph Reddy, Philip Low (2000)
Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation.Journal of controlled release : official journal of the Controlled Release Society, 64 1-3
-
T. Tejada‐Berges, C. Granai, M. Gordinier, W. Gajewski (2002)
Caelyx/Doxil for the treatment of metastatic ovarian and breast cancerExpert Review of Anticancer Therapy, 2
-
M. Lima, S. Simões, P. Pires, H. Faneca, N. Düzgüneş (2001)
Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.Advanced drug delivery reviews, 47 2-3
-
V. Baekelandt, B. Strooper, B. Nuttin, Z. Debyser (2000)
Gene therapeutic strategies for neurodegenerative diseases.Current opinion in molecular therapeutics, 2 5
-
R. Yu, R. Geary, J. Leeds, Tanya Watanabe, J. Fitchett, J. Matson, R. Mehta, Gregory Hardee, M. Templin, Ken Huang, M. Newman, Y. Quinn, P. Uster, G. Zhu, P. Working, M. Horner, J. Nelson, A. Levin (1999)
Pharmacokinetics and Tissue Disposition in Monkeys of an Antisense Oligonucleotide Inhibitor of Ha-Ras Encapsulated in Stealth LiposomesPharmaceutical Research, 16
-
W. Godbey, A. Mikos (2001)
Recent progress in gene delivery using non-viral transfer complexes.Journal of controlled release : official journal of the Controlled Release Society, 72 1-3
-
R. Bennett (1993)
As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells.Antisense research and development, 3 3
-
H. Petersen, P. Fechner, D. Fischer, T. Kissel (2002)
Synthesis, Characterization, and Biocompatibility of Polyethylenimine-graft-poly(ethylene glycol) Block CopolymersMacromolecules, 35
-
V. Calenda, P. Leissner, M. Marigliano, M. Mehtali (1996)
Gene therapy for HIV infection.Hematology and cell therapy, 38 2
-
E. Fattal, J. Delattre, C. Dubernet, P. Couvreur (1999)
Liposomes for the delivery of nucleotides and oligonucleotidesStp Pharma Sciences, 9
-
O. Greco, Brian Marples, Brian Marples, G. Dachs, Kaye Williams, Adam Patterson, Simon Scott, Simon Scott (2002)
Novel chimeric gene promoters responsive to hypoxia and ionizing radiationGene Therapy, 9
-
C. Nyberg-Hoffman, E. Aguilar‐Cordova (1999)
Instability of adenoviral vectors during transport and its implication for clinical studiesNature Medicine, 5
-
S. Patil, D. Rhodes, D. Burgess (2005)
Biophysical characterization of anionic lipoplexes.Biochimica et biophysica acta, 1711 1
-
G. Ommen (2002)
The Human Genome Project and the future of diagnostics, treatment and preventionJournal of Inherited Metabolic Disease, 25
-
M. Filion, N. Phillips (1997)
Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells.Biochimica et biophysica acta, 1329 2
-
E. Bachrach, M. Pelegrin, M. Piechaczyk, F. Pedersen, M. Duch (2002)
Efficient gene transfer into spleen cells of newborn mice by a replication-competent retroviral vector.Virology, 293 2
-
Robert Lee, Leaf Huang (1997)
Lipidic vector systems for gene transfer.Critical reviews in therapeutic drug carrier systems, 14 2
-
J. Jeong, T. Park (2002)
Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers.Journal of controlled release : official journal of the Controlled Release Society, 82 1
-
J. Bertrand, Mireille Pottier, A. Vekris, P. Opolon, A. Maksimenko, C. Malvy (2002)
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.Biochemical and biophysical research communications, 296 4
-
Y. Sviridov, R. Zhdanov, O. Podobed, T. Tsvetkova, I. Konstantinov, E. Bogdanenko (2001)
The lacZ gene transfer into L929 cells and [14C]-DNA tissue distribution following intraperitoneal administration of new pH-sensitive lipoplexes in mice.Cytobios, 106 Suppl 1
-
David Favre, Nathalie Provost, V. Blouin, Gilles Blancho, Y. Chérel, Anna Salvetti, P. Moullier (2001)
Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle.Molecular therapy : the journal of the American Society of Gene Therapy, 4 6
-
T. Merdan, J. Kopeček, T. Kissel (2002)
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.Advanced drug delivery reviews, 54 5
-
A. Horner, J. Uden, J. Zubeldia, D. Broide, E. Raz (2001)
DNA‐based immunotherapeutics for the treatment of allergic diseaseImmunological Reviews, 179
-
Magnus Köping-Höggård, I. Tubulekas, H. Guan, K. Edwards, Mats Nilsson, K. Vårum, P. Artursson (2001)
Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivoGene Therapy, 8
-
S. Kang, E. Zirbes, R. Kole (1999)
Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.Antisense & nucleic acid drug development, 9 6
-
A. Lever (1996)
Review Anti-infectives: Gene therapy in the fight against AIDSExpert Opinion on Therapeutic Patents, 6
-
A. Aigner, H. Juhl, C. Malerczyk, Anja Tkybusch, C. Benz, F. Czubayko (2001)
Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferationOncogene, 20
-
Widdas Wf, Baker Gf (2001)
The surface energy of water: the largest but forgotten source of energy in biological systems.Cytobios, 106
-
B. Khaw, J. DaSilva, I. Vural, J. Narula, V. Torchilin (2001)
Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes.Journal of controlled release : official journal of the Controlled Release Society, 75 1-2
-
Michael McManus, P. Sharp (2002)
Gene silencing in mammals by small interfering RNAsNature Reviews Genetics, 3
-
J. Legendre, Francis Jr (1992)
Delivery of Plasmid DNA into Mammalian Cell Lines Using pH-Sensitive Liposomes: Comparison with Cationic LiposomesPharmaceutical Research, 9
-
S. Agrawal, R. Zhang (2007)
Pharmacokinetics of oligonucleotides.Ciba Foundation symposium, 209
-
C. Stein, C. Subasinghe, K. Shinozuka, J. Cohen (1988)
Physicochemical properties of phosphorothioate oligodeoxynucleotides.Nucleic acids research, 16 8
-
A. Holmes, A. Dohrman, A. Ellison, K. Goncz, D. Gruenert (1999)
Intracellular Compartmentalization of DNA Fragments in Cultured Airway Epithelial Cells Mediated by Cationic LipidsPharmaceutical Research, 16
-
S. Crooke (1998)
An overview of progress in antisense therapeutics.Antisense & nucleic acid drug development, 8 2
-
Kyle Garton, N. Ferri, E. Raines (2002)
Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors.BioTechniques, 32 4
-
Leaf Huang, M. Hung, E. Wagner (1999)
Nonviral vectors for gene therapy -
N. Green, S. Hale (2002)
Viral approaches to cancer gene therapyExpert Opinion on Therapeutic Patents, 12
-
I. Jääskeläinen, J. Mönkkönen, A. Urtti (1994)
Oligonucleotide-cationic liposome interactions. A physicochemical study.Biochimica et biophysica acta, 1195 1
-
Wenjin Guo, Michael Gosselin, Robert Lee (2002)
Characterization of a novel diolein-based LPDII vector for gene delivery.Journal of controlled release : official journal of the Controlled Release Society, 83 1
-
Hoon Yoo, Rudy Juliano (2000)
Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.Nucleic acids research, 28 21
-
R. Owens (2002)
Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1.Current gene therapy, 2 2
-
Kenneth Culver, R. Blaese (1994)
Gene therapy for cancer.Trends in genetics : TIG, 10 5
-
A. Bout (1996)
Prospects for human gene therapyEuropean Journal of Drug Metabolism and Pharmacokinetics, 21
-
(2003)
DNA-based Biopharmaceuticals: therapeutics for the 21st Century -
S. Crooke (1999)
Molecular mechanisms of action of antisense drugs.Biochimica et biophysica acta, 1489 1
-
O. Khatsenko, R. Morgan, L. Truong, C. York-Defalco, H. Sasmor, B. Conklin, R. Geary (2000)
Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length.Antisense & nucleic acid drug development, 10 1
-
S. Crooke (1998)
Vitravene--another piece in the mosaic.Antisense & nucleic acid drug development, 8 4
-
Y. Kawamata, Y. Nagayama, K. Nakao, H. Mizuguchi, T. Hayakawa, Toshinori Sato, N. Ishii (2002)
Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro.Biomaterials, 23 23
-
S. Crooke (1995)
Delivery of oligonucleotides and polynucleotides.Journal of drug targeting, 3 3
-
L. Smith, K. Andersen, L. Hovgaard, J. Jaroszewski (2000)
Rational selection of antisense oligonucleotide sequences.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 11 3
-
B. Zinselmeyer, S. Mackay, A. Schatzlein, I. Uchegbu (2002)
The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer AgentsPharmaceutical Research, 19
-
Y. Shoji, S. Akhtar, A. Periasamy, B. Herman, R. Juliano (1991)
Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages.Nucleic acids research, 19 20
-
S. Audouy, G. Molema, L. Leij, D. Hoekstra (2000)
Serum as a modulator of lipoplex‐mediated gene transfection: dependence of amphiphile, cell type and complex stabilityThe Journal of Gene Medicine, 2
-
A. Rosenzweig (1999)
Vectors for Gene TherapyCurrent Protocols in Human Genetics, 52
-
F. Galimi, Inder Verma (2002)
Opportunities for the use of lentiviral vectors in human gene therapy.Current topics in microbiology and immunology, 261
-
A. Maclean, G. Symonds, R. Ward (1997)
Immunoliposomes as targeted delivery vehicles for cancer therapeutics (Review).International journal of oncology, 11 2
-
W. Walther, U. Stein (1996)
Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targetingJournal of Molecular Medicine, 74
-
Maureen Brown, A. Schätzlein, I. Uchegbu (2001)
Gene delivery with synthetic (non viral) carriers.International journal of pharmaceutics, 229 1-2
-
E. Galanis, S. Russell (2001)
Cancer gene therapy clinical trials: lessons for the futureBritish Journal of Cancer, 85
-
C. Mah, B. Byrne, T. Flotte (2002)
Virus-Based Gene Delivery SystemsClinical Pharmacokinetics, 41
-
M. Bentires-Alj, A. Hellin, C. Lechanteur, F. Princen, Miguel López, G. Fillet, J. Gielen, M. Merville, V. Bours (2000)
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisCancer Gene Therapy, 7
-
J. Marshall, N. Yew, S. Eastman, Canwen Jiang, R. Scheule, Seng Cheng (1999)
Cationic Lipid-Mediated Gene Delivery to the Airways -
J. Wolf, A. Jenkins (2002)
Gene therapy for ovarian cancer (review).International journal of oncology, 21 3
-
J. Lehoux, F. Grondin (1993)
Some effects of chitosan on liver function in the rat.Endocrinology, 132 3
-
G. Lemkine, B. Demeneix (2001)
Polyethylenimines for in vivo gene delivery.Current opinion in molecular therapeutics, 3 2
-
Sudhir Agrawal, Weitian Tan, Quiyin Cai, Xiaowei Xie, Ruiwen Zhang (1997)
In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines.Antisense & nucleic acid drug development, 7 3
-
R. Tachibana, H. Harashima, Y. Shinohara, H. Kiwada (2001)
Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors.Advanced drug delivery reviews, 52 3
-
T. Connors (1995)
The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.Gene therapy, 2 10
-
Liang Xu, Cheng-Cheng Huang, Weiqun Huang, Wen-hua Tang, A. Rait, Yuzhi Yin, I. Cruz, Laiman Xiang, K. Pirollo, E. Chang (2002)
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.Molecular cancer therapeutics, 1 5
-
I. Jääskeläinen, B. Sternberg, J. Mönkkönen, A. Urtti (1998)
Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotidesInternational Journal of Pharmaceutics, 167
-
J. Felgner, Raj Kumar, C. Sridhar, C. Wheeler, Y. Tsai, Richard Border, P. Ramsey, M. Martín, P. Felgner (1994)
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.The Journal of biological chemistry, 269 4
-
T. Timme, S. Hall, R. Barrios, S. Woo, E. Aguilar‐Cordova, T. Thompson (1998)
Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.Cancer gene therapy, 5 2
-
Lei Zhang, W. Gasper, S. Stass, O. Ioffe, Myrtle Davis, A. Mixson (2002)
Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2.Cancer research, 62 19
-
Hiroyuki Kamiya, Hiroyuki Tsuchiya, J. Yamazaki, Hideyoshi Harashima (2001)
Intracellular trafficking and transgene expression of viral and non-viral gene vectors.Advanced drug delivery reviews, 52 3
-
Aparna Lakkaraju, J. Dubinsky, W. Low, Y. Rahman (2001)
Neurons Are Protected from Excitotoxic Death by p53 Antisense Oligonucleotides Delivered in Anionic Liposomes*The Journal of Biological Chemistry, 276
-
H. Lee, S. Williams, S. Allison, T. Anchordoquy (2001)
Analysis of self-assembled cationic lipid-DNA gene carrier complexes using flow field-flow fractionation and light scattering.Analytical chemistry, 73 4
-
J. Engels, E. Uhlmann (2003)
Chemistry of OligonucleotidesChemInform, 32
-
Brenda Baker (2001)
THE ROLE OF ANTISENSE OLIGONUCLEOTIDES IN THE WAVE OF GENOMIC INFORMATIONNucleosides, Nucleotides & Nucleic Acids, 20
-
W. Krauss, J. Park, D. Kirpotin, K. Hong, C. Benz (2000)
Emerging antibody-based HER2 (ErbB-2/neu) therapeutics.Breast disease, 11
-
R. Weeratna, T. Wu, S. Efler, L. Zhang, H. Davis (2001)
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promotersGene Therapy, 8
-
S. Rowland-Jones (1999)
HIV infection: where have all the T cells gone?The Lancet, 354
-
C. Ward, M. Pechar, D. Oupický, K. Ulbrich, L. Seymour (2002)
Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivoThe Journal of Gene Medicine, 4
-
S. Wu‐Pong (2000)
Alternative interpretations of the oligonucleotide transport literature: insights from nature.Advanced drug delivery reviews, 44 1
-
V. Arruda, P. Fields, R. Milner, L. Wainwright, M. Miguel, P. Donovan, R. Herzog, T. Nichols, J. Biegel, J. Biegel, M. Razavi, M. Dake, D. Huff, A. Flake, L. Couto, M. Kay, K. High (2001)
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.Molecular therapy : the journal of the American Society of Gene Therapy, 4 6
-
Akin Akinc, R. Langer (2002)
Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking.Biotechnology and bioengineering, 78 5
-
(1999)
Polymeric gene delivery systems for in vivo gene therapy. Drug Targeting and Delivery -
D. Luo, W. Saltzman (2000)
Synthetic DNA delivery systemsNature Biotechnology, 18
-
M. Hughes, Majad Hussain, Qamar Nawaz, P. Sayyed, S. Akhtar (2001)
The cellular delivery of antisense oligonucleotides and ribozymes.Drug discovery today, 6 6
-
(2000)
Comparison of Lipid-Mediated and Adenoviral Gene Transfer in Human Monocyte-Derived Macrophages and COS-7 Cells -
Carl Wheeler, P. Felgner, Yali Tsai, John Marshall, L. Sukhu, Soeun Doh, J. Hartikka, J. Nietupski, Marston Manthorpe, Margaret Nichols, Michael Plewe, Xiaowu Liang, Jon Norman, Alan Smith, Seng Cheng (1996)
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.Proceedings of the National Academy of Sciences of the United States of America, 93 21
-
B. Florea, C. Meaney, H. Junginger, G. Borchard (2002)
Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell culturesAAPS PharmSci, 4
-
S. Patil, D. Rhodes, D. Burgess (2004)
Anionic liposomal delivery system for DNA transfectionThe AAPS Journal, 6
-
M. Wolfert, L. Seymour (1998)
Chloroquine and amphipathic peptide helices show synergistic transfection in vitroGene Therapy, 5
-
M. Kay, J. Glorioso, L. Naldini (2001)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeuticsNature Medicine, 7
-
I. Wong (2001)
Methylation profiling of human cancers in blood: molecular monitoring and prognostication (review).International journal of oncology, 19 6
-
A. Thierry, E. Vivés, J. Richard, P. Prévot, Camille Martinand-Mari, I. Robbins, B. Lebleu (2003)
Cellular uptake and intracellular fate of antisense oligonucleotides.Current opinion in molecular therapeutics, 5 2
-
Z. Cui, R. Mumper (2001)
Chitosan-based nanoparticles for topical genetic immunization.Journal of controlled release : official journal of the Controlled Release Society, 75 3
-
M. Lotze, T. Kost (2002)
Viruses as gene delivery vectors: Application to gene function, target validation, and assay developmentCancer Gene Therapy, 9
-
A. Singla, Manisha Chawla (2001)
Chitosan: some pharmaceutical and biological aspects ‐ an updateJournal of Pharmacy and Pharmacology, 53
-
L. Tenenbaum, E. Lehtonen, P. Monahan (2003)
Evaluation of risks related to the use of adeno-associated virus-based vectors.Current gene therapy, 3 6
-
B. Freimark, Blezinger Hp, Florack Vj, Jeff Nordstrom, Long Sd, Deepa Deshpande, S. Nochumson, K. Petrak (1998)
Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes.Journal of immunology, 160 9
-
J. Eichman, A. Bielinska, J. Kukowska-Latallo, J. Baker (2000)
The use of PAMAM dendrimers in the efficient transfer of genetic material into cells.Pharmaceutical science & technology today, 3 7
-
B. Cao, J. Mytinger, J. Huard (2002)
Adenovirus mediated gene transfer to skeletal muscleMicroscopy Research and Technique, 58
-
S. Johnston, A. Talaat, M. Mcguire (2002)
Genetic immunization: what's in a name?Archives of medical research, 33 4
-
S. Patil, D. Rhodes (2000)
Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study.Nucleic acids research, 28 12
-
M. Scherr, Michael Morgan, M. Eder (2003)
Gene silencing mediated by small interfering RNAs in mammalian cells.Current medicinal chemistry, 10 3
-
L. Johnson (1995)
Gene therapy for cystic fibrosis.Chest, 107 2 Suppl
-
S. Vorburger, K. Hunt (2002)
Adenoviral gene therapy.The oncologist, 7 1
-
Hwang Sj, Mark Davis (2001)
Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration.Current opinion in molecular therapeutics, 3 2
-
F. Leclercq, C. Dubertret, B. Pitard, D. Scherman, J. Herscovici (2000)
Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency.Bioorganic & medicinal chemistry letters, 10 11
-
Jun Kunisawa, S. Nakagawa, Tadanori Mayumi (2001)
Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development.Advanced drug delivery reviews, 52 3
-
Wenli Zhao, Masanobu Kobayashi, M. Hosokawa, P. Seth (2002)
Adenoviral Vectors for Cancer Gene TherapyCurrent Genomics, 3
-
Feng Liu, H. Qi, Leaf Huang, Dexi Liu (1997)
Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administrationGene Therapy, 4
-
S. Patil, D. Rhodes (2000)
Conformation of oligodeoxynucleotides associated with anionic liposomes.Nucleic acids research, 28 21
-
L. Qin, Yaozhong Ding, D. Pahud, E. Chang, M. Imperiale, J. Bromberg (1997)
Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene ExpressionHuman Gene Therapy, 8
-
Yvonne Perrie, Gregory Gregoriadis (2000)
Liposome-entrapped plasmid DNA: characterisation studies.Biochimica et biophysica acta, 1475 2
-
V. Regnier, A. Tahiri, N. André, M. Lemaitre, T. Doan, V. Préat (2000)
Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin.Journal of controlled release : official journal of the Controlled Release Society, 67 2-3
-
S. Dokka, D. Toledo, Xianglin Shi, V. Castranova, Y. Rojanasakul (2000)
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic LiposomesPharmaceutical Research, 17
-
G. Borchard (2001)
Chitosans for gene delivery.Advanced drug delivery reviews, 52 2
-
S. Jayasena (1999)
Aptamers: an emerging class of molecules that rival antibodies in diagnostics.Clinical chemistry, 45 9
-
C. Lollo, M. Banaszczyk, P. Mullen, C. Coffin, Dongpei Wu, A. Carlo, Donna Bassett, Erin Gouveia, D. Carlo (2002)
Poly- L -Lysine-Based Gene Delivery SystemsMethods in molecular medicine, 69
-
Patrick Fillion, Annie Desjardins, K. Sayasith, Jacqueline Lagacé (2001)
Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides.Biochimica et biophysica acta, 1515 1
-
S. Takeda, Y. Nabeshima (1995)
[Gene therapy in muscular dystrophy].Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 40 17
-
M. Martínez, A. Gutiérrez, Mercedes Armand-Ugón, J. Blanco, M. Parera, Jordi Gómez, B. Clotet, J. Esté (2002)
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replicationAIDS, 16
-
M. Matteucci (1996)
Structural modifications toward improved antisense oligonucleotidesPerspectives in Drug Discovery and Design, 4
-
S. Akhtar, M. Hughes, M. Hughes, Alim Khan, Alim Khan, M. Bibby, Majad Hussain, Majad Hussain, Qamar Nawaz, Qamar Nawaz, J. Double, P. Sayyed, P. Sayyed (2000)
The delivery of antisense therapeutics.Advanced drug delivery reviews, 44 1
-
F. Paillard (1997)
Advantages of Non-Human Adenoviruses Versus Human Adenoviruses Promoter Attenuation in Gene Therapy: Causes and RemediesHuman Gene Therapy, 8
-
P. Zamore, N. Aronin (2003)
siRNAs knock down hepatitisNature Medicine, 9
-
J. Kurreck (2003)
Antisense technologies. Improvement through novel chemical modifications.European journal of biochemistry, 270 8
-
K. Martin, R. Klein, H. Quigley (2002)
Gene delivery to the eye using adeno-associated viral vectors.Methods, 28 2
-
Michael Hope, B. Mui, S. Ansell, Q. Ahkong (1998)
Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).Molecular membrane biology, 15 1
-
S. Ylä-Herttuala, A. Ollikainen, M. Vapalahti (1996)
[Human gene therapy].Duodecim; laaketieteellinen aikakauskirja, 112 2
-
W. Denny, W. Wilson (1998)
The Design of Selectively‐activated Anti‐cancer Prodrugs for use in Antibody‐directed and Gene‐directed Enzyme‐Prodrug Therapies *Journal of Pharmacy and Pharmacology, 50
-
L. Chaloin, M. Lehmann, G. Sczakiel, T. Restle (2002)
Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.Nucleic acids research, 30 18
-
C. Lollo, M. Banaszczyk, P. Mullen, C. Coffin, Dongpei Wu, A. Carlo, Donna Bassett, Erin Gouveia, D. Carlo (2002)
Poly-L-lysine-based gene delivery systems. Synthesis, purification, and application.Methods in molecular medicine, 69
-
P. Couvreur, C. Malvy, Villejuif (2000)
Pharmaceutical Aspects of Oligonucleotides -
S. McTaggart, M. Al‐Rubeai (2002)
Retroviral vectors for human gene delivery.Biotechnology advances, 20 1
-
M. Männistö, S. Vanderkerken, V. Toncheva, M. Elomaa, Marika Ruponen, E. Schacht, A. Urtti (2002)
Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery.Journal of controlled release : official journal of the Controlled Release Society, 83 1
-
W. Walther, U. Stein (2000)
Gene Therapy of Cancer -
N. Shi, Yun Zhang, Chunni Zhu, R. Boado, W. Pardridge (2001)
Brain-specific expression of an exogenous gene after i.v. administrationProceedings of the National Academy of Sciences of the United States of America, 98
-
P. Venugopalan, Sanyog Jain, S. Sankar, Paramjit Singh, Amit Rawat, S. Vyas (2002)
pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.Die Pharmazie, 57 10
-
K. Lappalainen, I. Jääskeläinen, K. Syrjänen, A. Urtti, S. Syrjänen (1994)
Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic LiposomesPharmaceutical Research, 11
- Publisher
- Springer Journals
- Copyright
- Copyright © American Association of Pharmaceutical Scientists 2005
- eISSN
- 1550-7416
- DOI
- 10.1208/aapsj070109
- Publisher site
- See Article on Publisher Site
Abstract
The past several years have witnessed the evolution of gene medicine from an experimental technology into a viable strategy for developing therapeutics for a wide range of human disorders. Numerous prototype DNA-based biopharmaceuticals can now control disease progression by induction and/or inhibition of genes. These potent therapeutics include plasmids containing transgenes, oligonucleotides, aptamers, ribozymes, DNAzymes, and small interfering RNAs. Although only 2 DNA-based pharmaceuticals (an antisense oligonucleotide formulation, Vitravene, (USA, 1998), and an adenoviral gene therapy treatment, Gendicine (China, 2003), have received approval from regulatory agencies; numerous candidates are in advanced stages of human clinical trials. Selection of drugs on the basis of DNA sequence and structure has a reduced potential for toxicity, should result in fewer side effects, and therefore should eventually yield safer drugs than those currently available. These predictions are based on the high selectivity and specificity of such molecules for recognition of their molecular targets. However, poor cellular uptake and rapid in vivo degradation of DNA-based therapeutics necessitate the use of delivery systems to facilitate cellular internalization and preserve their activity. This review discusses the basis of structural design, mode of action, and applications of DNA-based therapeutics. The mechanisms of cellular uptake and intracellular trafficking of DNA-based therapeutics are examined, and the constraints these transport processes impose on the choice of delivery systems are summarized. Finally, the development of some of the most promising currently available DNA delivery platforms is discussed, and the merits and drawbacks of each approach are evaluated.
Journal
The AAPS Journal – Springer Journals
Published: Jan 28, 2008
Keywords: nucleic acid therapeutics; DNA delivery systems; nonviral vectors; viral vectors; liposomes; gene therapy